These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2673605)

  • 1. Clinical pharmacokinetics in patients with spinal cord injuries.
    Segal JL; Brunnemann SR
    Clin Pharmacokinet; 1989 Aug; 17(2):109-29. PubMed ID: 2673605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin bioavailability and single-dose pharmacokinetics in spinal cord injury.
    Segal JL; Brunnemann SR; Gray DR
    Drug Intell Clin Pharm; 1988 Jun; 22(6):461-5. PubMed ID: 3396458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of experimental spinal cord injury on carbamazepine pharmacokinetics.
    Reihani-Kermani H; Ansari M; Karamousian S
    Arch Iran Med; 2006 Jul; 9(3):231-5. PubMed ID: 16859057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute bioavailability of oral theophylline in patients with spinal cord injury.
    Segal JL; Brunnemann SR; Gordon SK; Eltorai IM
    Pharmacotherapy; 1986; 6(1):26-9. PubMed ID: 3952003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of aminoglycosides in patients with chronic spinal cord injury.
    Young F; Ensom MH
    Am J Health Syst Pharm; 2011 Sep; 68(17):1607-14. PubMed ID: 21856806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide-induced normalization of impaired gastric emptying in spinal cord injury.
    Segal JL; Milne N; Brunnemann SR; Lyons KP
    Am J Gastroenterol; 1987 Nov; 82(11):1143-8. PubMed ID: 3673993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of riluzole in acute spinal cord injury.
    Chow DS; Teng Y; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Johnson MM; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):129-40. PubMed ID: 22985379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury.
    Ibarra A; Guízar-Sahagún G; Correa D; Kretschmer R; Grijalva I; Flores-Murrieta FJ; Castañeda-Hernández G; Odor A; López RM; Franco-Bourland R; Espitia AL; Salgado-Ceballos H; Madrazo I
    J Neurotrauma; 1996 May; 13(5):267-72. PubMed ID: 8797176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug absorption in spinal cord injury.
    Halstead LS; Feldman S; Claus-Walker J; Patel VC
    Arch Phys Med Rehabil; 1985 May; 66(5):298-301. PubMed ID: 4004520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased systemic clearance of lorazepam in humans with spinal cord injury.
    Segal JL; Brunnemann SR; Eltorai IM; Vulpe M
    J Clin Pharmacol; 1991 Jul; 31(7):651-6. PubMed ID: 1894761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding drug disposition alterations induced by acute spinal cord injury: role of injury level and route of administration for agents submitted to extensive liver metabolism.
    Cruz-Antonio L; Flores-Murrieta FJ; García-Löpez P; Guízar-Sahagún G; Castañeda-Hernández G
    J Neurotrauma; 2006 Jan; 23(1):75-85. PubMed ID: 16430374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone disposition kinetics in patients with acute spinal cord injury.
    Segal JL; Maltby BF; Langdorf MI; Jacobson R; Brunnemann SR; Jusko WJ
    Pharmacotherapy; 1998; 18(1):16-22. PubMed ID: 9469676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of gacyclidine enantiomers after experimental spinal cord injury in rats: possible involvement of an active transport system.
    Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Lallemand A; Millart H; D'Arbigny P; Vistelle R
    J Pharm Sci; 2001 Jan; 90(1):70-8. PubMed ID: 11064380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin disposition kinetics in humans with spinal cord injury.
    Segal JL; Gray DR; Gordon SK; Eltorai IM; Khonsari F; Patel J
    Paraplegia; 1985 Feb; 23(1):47-55. PubMed ID: 3982847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoclopramide increases the bioavailability of dantrolene in spinal cord injury.
    Gilman TM; Segal JL; Brunnemann SR
    J Clin Pharmacol; 1996 Jan; 36(1):64-71. PubMed ID: 8932545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin pharmacokinetics in patients with spinal cord injury.
    Segal JL; Brunnemann SR; Gordon SK; Eltorai IM
    Pharmacotherapy; 1988; 8(2):79-81. PubMed ID: 3399423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut hormone release in patients after spinal cord injury.
    Saltzstein RJ; Mustin E; Koch TR
    Am J Phys Med Rehabil; 1995; 74(5):339-44. PubMed ID: 7576409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord injury sequelae alter drug pharmacokinetics: an overview.
    Mestre H; Alkon T; Salazar S; Ibarra A
    Spinal Cord; 2011 Sep; 49(9):955-60. PubMed ID: 21625241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.